Affymetrix, Partners HealthCare collaborate
This article was originally published in The Gray Sheet
Executive Summary
Diagnostics firm inks three-year translational research agreement with Partners managed care organization to develop microassay-based diagnostics for newborn hearing loss, autism, hypertrophic cardiomyopathy and other conditions. Partners is an integrated healthcare delivery system comprising Brigham & Women's Hospital and Massachusetts General in Boston. Partners' researchers at Harvard Medical School will create and validate the microarray tests in Clinical Laboratory Improvement Amendments-regulated labs. Affymetrix' Translational Medicine Program develops molecular signatures to create custom-designed microarray products that help researchers diagnose and tailor treatments for individual patients...